secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUCELL CORP /DE/ (ICCC)
CIK:        0000811641
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001437749-26-003514
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Two ImmuCell directors will not seek re-election at 2026 annual meeting
-----------------------------------------------------------------------

- Steven A. Rosgen and Bryan K. Gathagan will not stand for re-election, citing time constraints from full-time roles.
- Both directors expressed support for the company's new strategic direction and management.
- Nominating Committee is evaluating board composition changes, factoring in these retirements.
- Effective at the 2026 Annual Meeting of Shareholders; no replacements named yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811641/000143774926003514/0001437749-26-003514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811641/000143774926003514/iccc20260209_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-003514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer